APA aipamena

Herold, K. C., Bundy, B. N., Long, S. A., Bluestone, J. A., DiMeglio, L. A., Dufort, M. J., . . . Greenbaum, C. J. (2019). An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med.

Chicago Style aipamena

Herold, Kevan C., et al. "An Anti-CD3 Antibody, Teplizumab, in Relatives At Risk for Type 1 Diabetes." N Engl J Med 2019.

MLA aipamena

Herold, Kevan C., et al. "An Anti-CD3 Antibody, Teplizumab, in Relatives At Risk for Type 1 Diabetes." N Engl J Med 2019.